Defining a new era of oligonucleotides

Defining a new era of oligonucleotides

4

SEC Filing Details

Document Details

Form
Filing Date
Aug 16, 2019
Document Date
Aug 15, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Wave Life Sciences
Issuer
Wave Life Sciences Ltd.
Filer
Rawcliffe Adrian